Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome

Melissa Kahsar-Miller, Larry R. Boots, Ricardo Azziz

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.

Original languageEnglish (US)
Pages (from-to)436-438
Number of pages3
JournalFertility and Sterility
Volume71
Issue number3
DOIs
StatePublished - Jan 1 1999

Fingerprint

Dopamine D3 Receptors
Polycystic Ovary Syndrome
Southeastern United States
Alleles
Genotype
Endocrinology
Ambulatory Care Facilities
Hispanic Americans
Population
Case-Control Studies
Outcome Assessment (Health Care)
Genes

Keywords

  • Dopamine D receptor gene
  • Polycystic ovary syndrome
  • Polymorphism

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. / Kahsar-Miller, Melissa; Boots, Larry R.; Azziz, Ricardo.

In: Fertility and Sterility, Vol. 71, No. 3, 01.01.1999, p. 436-438.

Research output: Contribution to journalArticle

Kahsar-Miller, Melissa ; Boots, Larry R. ; Azziz, Ricardo. / Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. In: Fertility and Sterility. 1999 ; Vol. 71, No. 3. pp. 436-438.
@article{122d20f89d8e4082a0e4bbece9a30241,
title = "Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome",
abstract = "Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.",
keywords = "Dopamine D receptor gene, Polycystic ovary syndrome, Polymorphism",
author = "Melissa Kahsar-Miller and Boots, {Larry R.} and Ricardo Azziz",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0015-0282(98)00485-3",
language = "English (US)",
volume = "71",
pages = "436--438",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome

AU - Kahsar-Miller, Melissa

AU - Boots, Larry R.

AU - Azziz, Ricardo

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.

AB - Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.

KW - Dopamine D receptor gene

KW - Polycystic ovary syndrome

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0032586940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032586940&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(98)00485-3

DO - 10.1016/S0015-0282(98)00485-3

M3 - Article

C2 - 10065778

AN - SCOPUS:0032586940

VL - 71

SP - 436

EP - 438

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -